The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of ctDNA whole-exome sequencing in pancreatic adenocarcinoma on prognostic value, actionable alterations, and organ tropisms in metastatic disease.
 
Marisol Huerta
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - Merck; SERVIER
 
Jorge Martín-Arana
No Relationships to Disclose
 
Francisco Gimeno-Valiente
No Relationships to Disclose
 
Juan Antonio Carbonell-Asins
No Relationships to Disclose
 
Blanca García-Micó
No Relationships to Disclose
 
Belén Martínez-Castedo
No Relationships to Disclose
 
Daniel G. Camblor
No Relationships to Disclose
 
Tania Fleitas
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb/Sanofi; MSD Oncology; MSD Oncology; Roche; Servier/Pfizer
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; SERVIER
 
Miguel García Bartolomé
Speakers' Bureau - Pfizer
 
Clara Alfaro-Cervello
No Relationships to Disclose
 
Marina Garcés-Albir
Speakers' Bureau - Baxter
Travel, Accommodations, Expenses - Prim
 
Dimitri Dorcaratto
No Relationships to Disclose
 
Elena Muñoz-Forner
No Relationships to Disclose
 
Isabel Mora-Oliver
Travel, Accommodations, Expenses - Viatris
 
Valentina Gambardella
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Amcure (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Natera (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst); Sierra Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Susana Roselló-Keränen
Research Funding - GlaxoSmithKline (Inst); Inspirna (Inst); Janssen Oncology (Inst); Mirati Therapeutics (Inst); Nouscom (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Luis Sabater
No Relationships to Disclose
 
Desamparados Roda
Consulting or Advisory Role - Abbvie
Travel, Accommodations, Expenses - SERVIER
 
Andres Cervantes
Consulting or Advisory Role - Amgen (Inst); Foundation Medicine (Inst); Merck Serono (Inst); Roche (Inst); Transgene (Inst)
Research Funding - Actuate Therapeutics (Inst); Adaptimmune (Inst); Amcure (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer (Inst); BeiGene (Inst); BMSi (Inst); FibroGen (Inst); Genentech (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Natera (Inst); Novartis (Inst); SERVIER (Inst); Sierra Oncology (Inst); Takeda (Inst)
Other Relationship - Annals of Oncology; Cancer Treatment Reviews; ESMO Open
 
Noelia Tarazona
Consulting or Advisory Role - Grifols; Guardant Health; Merck
Speakers' Bureau - Amgen; Merck; Pfizer; SERVIER
Research Funding - Natera
Travel, Accommodations, Expenses - Amgen; International Society of Liquid Biopsy; Merck; SERVIER